Literature DB >> 2180771

Comparative study between ultrasound, computed tomography, intra-arterial digital subtraction angiography, and magnetic resonance imaging in the differentiation of tumors of the liver.

L Vlachos1, S Trakadas, A Gouliamos, S Lazarou, D Mourikis, R Ioannou, A Kalovidouris, C Papavasiliou.   

Abstract

Forty-one patients with liver tumor have been evaluated with ultrasound (US), computed tomography (CT), intra-arterial digital subtraction angiography (IA-DSA), and magnetic resonance imaging (MRI) in order to establish the accuracy of each technique. In group A (24 patients), in which all four imaging modalities were performed, our results show that MRI detected all hemangiomas (25/25) compared to 22/25, 21/25, and 20/25 with US, CT, and IA-DSA, respectively. No difference between the various methods was seen in the case of hepatoma. Finally, in the patients with metastases, all four techniques had the same sensitivity (100%) but the specificity of MRI was also 100%, compared to 33% for IA-DSA and 66% for US and CT.

Entities:  

Mesh:

Year:  1990        PMID: 2180771     DOI: 10.1007/BF01888749

Source DB:  PubMed          Journal:  Gastrointest Radiol        ISSN: 0364-2356


  9 in total

1.  Mass lesions of the liver.

Authors:  M A Adson
Journal:  Mayo Clin Proc       Date:  1986-05       Impact factor: 7.616

2.  Computed tomography and sonography of cavernous hemangioma of the liver.

Authors:  Y Itai; K Ohtomo; T Araki; S Furui; M Iio; Y Atomi
Journal:  AJR Am J Roentgenol       Date:  1983-08       Impact factor: 3.959

3.  Hepatic metastases studied with MR and CT.

Authors:  J P Heiken; J K Lee; H S Glazer; D Ling
Journal:  Radiology       Date:  1985-08       Impact factor: 11.105

4.  Liver metastasis detection: comparative sensitivities of MR imaging and CT scanning.

Authors:  J W Reinig; A J Dwyer; D L Miller; M White; J A Frank; P H Sugarbaker; A E Chang; J L Doppman
Journal:  Radiology       Date:  1987-01       Impact factor: 11.105

5.  Evaluation of focal hepatic masses: a comparative study of MRI and CT.

Authors:  G M Glazer; A M Aisen; I R Francis; B H Gross; J W Gyves; W D Ensminger
Journal:  Gastrointest Radiol       Date:  1986

6.  Leo J. Rigler lecture. MR imaging of the liver.

Authors:  J T Ferrucci
Journal:  AJR Am J Roentgenol       Date:  1986-12       Impact factor: 3.959

7.  Differentiation of hepatic metastases from hepatic hemangiomas and cysts by using MR imaging.

Authors:  J Wittenberg; D D Stark; B H Forman; P F Hahn; S Saini; R Weissleder; E Rummeny; J T Ferrucci
Journal:  AJR Am J Roentgenol       Date:  1988-07       Impact factor: 3.959

8.  Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization.

Authors:  D D Stark; R C Felder; J Wittenberg; S Saini; R J Butch; M E White; R R Edelman; P R Mueller; J F Simeone; A M Cohen
Journal:  AJR Am J Roentgenol       Date:  1985-08       Impact factor: 3.959

9.  Hepatic tumors: magnetic resonance and CT appearance.

Authors:  A A Moss; H I Goldberg; D B Stark; P L Davis; A R Margulis; L Kaufman; L E Crooks
Journal:  Radiology       Date:  1984-01       Impact factor: 11.105

  9 in total
  4 in total

1.  Staging of hepatocellular carcinoma by ultrasonography, computed tomography, and angiography: the role of CT combined with arterial portography.

Authors:  F Garbagnati; C Spreafico; A Marchianò; M Salvetti; C Segura; G Piragine
Journal:  Gastrointest Radiol       Date:  1991

2.  MRI of abdominal hydatid disease.

Authors:  A Kalovidouris; A Gouliamos; L Vlachos; A Papadopoulos; D Voros; S Pentea; C Papavasiliou
Journal:  Abdom Imaging       Date:  1994 Nov-Dec

3.  Preoperative evaluation of patients for liver resection. Appropriate CT imaging.

Authors:  R C Karl; S S Morse; R D Halpert; R A Clark
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

4.  Customized low-cost high-throughput amplifier for electro-fluidic detection of cell volume changes in point-of-care applications.

Authors:  Saurabh Kaushik; Prabhakaran Selvanathan; Gautam Vivek Soni
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.